Clinical Trial

Hepatoprotective for Children and Adolescent With Acute Lymphoblastic Leukemia

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated April 9, 2025 (before its estimated May 2025 completion). Its status may not reflect the trial's current state.
Summary
This current study will implement a proposed whole program of monitoring and prevention acute hepatic injury during the time of induction chemotherapy in children and adolescent with ALL.
Trial Details
NCT Number NCT06918054
Lead Sponsor Ain Shams University
Conditions Leukaemia (Acute), Acute Lymphoblastic Leukemia
Enrollment 42 participants
Start Date 2023-11-17
Primary Completion 2025-05 (estimated)
Study Completion 2025-08 (estimated)
Updated on ClinicalTrials.gov 2025-04-09